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DVH parameters and optimization objectives were 
extracted from archived DVH reports. Data were analysed 
in SPSS. 
Results 
In 10.7% (n=19) of cases the auto-plan was directly 
accepted for treatment. In 46.9% (n=83) of cases, MUs 
were scaled before accepting the auto-plan. In 40.1% 
(n=71), the auto-plan was optimised further. In 2.3% (n=4) 
of all cases, the auto-plan was rejected entirely and a new 
plan was made manually. We could identify the following 
reasons for manual adaptations: 
  
 Bowel loop: 14.7% of plans (n=26), a bowel loop 
was near the PTV. In 4 cases MU were scaled and 
22 cases were optimised further.  
 Target coverage: Upscaling of MUs (n=43) is 
done to improve target coverage. These auto-
plans had a mean V95% of 98.87±1.12%, upscaling 
resulted in a mean V95% of 99.41±0.25% 
(p<0.001).  
 Hot or cold spots: Downscaling of MUs (n=40) is 
mainly done to reduce the high dose volume. 
Before downscaling, auto-plans had a V103% of 
1.11±1.39%, downscaling resulted in a V103% of 
0.48±0.62% (p=0.002). In 22 cases additional 
objectives were required to counteract hot or 
cold spots in the plan.  
 
Figure 1 shows PTV coverage of the auto-plan vs the 
clinical plan and denotes the reason for manual 
adaptation. These adaptations had no significant effect 
OAR mean dose (rectum, anal sphincter) (p>0.141). All 
manual plans were made due to the presence of a hip 
prosthesis or bowel loop. 
Conclusion 
Although, clinical plans were based on the auto-plan in 
97.7% of cases, the direct acceptance rate of auto-plans, 
including a post-script for fine tuning, was low at 10.2%. 
Rescaling of MU’s was the most performed adaptation, 
which is easily automated by adding an auto-prescribe 
step. Overall, the effects of plan adaptations were small 
and might not have been clinically relevant. These data 
give rise to further discussion between physicists, 
physicians and RTTs to provide inside into what manual 
adaptations would be clinically relevant. Development of 
automated decisions tools to identify non-optimal 
treatment plans may be of great value for improvement of 
auto-planning practice. 
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Purpose or Objective 
There are as many variations in tumor location, shape and 
size in lymphoma patients, as in radiotherapy (RT) 
techniques clinically applied (Maraldo et al. Int J Radiat 
Oncol Biol Phys 2015, 92(1):151). This population might 
therefore benefit from patient-specific, computer 
selection of beam angles. We investigated the potential 
dosimetric advantages of automated beam angle selection 
(BAS), in both coplanar (CP) and non-coplanar (NCP) 
settings, for young mediastinal lymphoma females, with 
or without involvement of supraclavicular or axillar nodes, 
including bulky disease. 
Material and Methods 
A total of 23 patients were included with mediastinal 
lymphoma disease (PTV sizes: 97cc – 1308cc, median: 
495cc; median age: 26 years). Erasmus-iCycle was used to 
automatically generate treatment plans with/without 
BAS. The applied optimization protocol as defined by the 
‘wish-list’ containing the planning hard constraints and 
prioritized objectives was tailored to RT of young females, 
where late toxicity to breasts, heart, and lungs are of 
great concern. The prescription dose was 30 Gy. Coplanar 
(BAS-CP) and fully non-coplanar (BAS-fNCP) plans were 
generated (min. beams=5, max.=15), for couch and gantry 
angles that are possible at the treatment unit. The optimal 
number of beams and the most common couch positions 
were investigated. For a subgroup of 16 patients, CP IMRT 
plans were generated with the clinically used beam 
angles, typically 5-7 beams manually selected from (and 
close to) anterior and posterior directions (CLIN-CP). 
Results 
BAS-CP plans with the same number of beams as the CLIN-
CP plans resulted in similar OAR doses for the same PTV 
coverage (V95%=98%), but lower integral patient dose 
(V15Gy, V20Gy). The addition of CP beams (10 vs 5) 
resulted in (1) improvements in heart and lung Dmean for 
all patients, on average -0.7 Gy (max. -2.4 Gy), and -0.8 
Gy (max. -1.6 Gy) improvement respectively; (2) decrease 
in lung V5Gy by more than 5% for 6 patients; and (3) a 
decrease in patients with breast Dmean over 2 Gy (5 vs 8). 
BAS-fNCP plans showed further reductions in OAR doses 
relative to BAS-CP: (1) the average lung and heart Dmean 
were lower by 0.5 Gy and 0.7 Gy, respectively; (2) a 
decrease in heart Dmean >1 Gy was found for 8 patients 
(max. 2.4 Gy); (3) a decrease in lung Dmean ≥1 Gy for 5 
patients (max. 1.9 Gy), along with reductions in lung V5Gy 
ranging from 6–20%, and (4) less patients with breast 
Dmean over 2 Gy (3 vs 5). BAS-fNCP with 15 beams resulted 
in the largest differences with CLIN-CP, with 
improvements (mean±SD) of -1.3±1.2 Gy (max. -3.6 Gy) 
and -1.2±0.7 Gy (max. -3.0 Gy) for the heart and lung 
Dmean, respectively, and 5% lower lung V5Gy on average 
(max. 20%), while the Dmean on both breasts was <2 Gy 
for 15/16 for BAS-fNCP, compared to 13/16 with CLIN-CP. 
 
 
 
Conclusion 
We successfully implemented automated planning for 
young female lymphoma patients. Patient-specific 
computer optimization of (non-coplanar) beam angles can 
significantly reduce doses to breast, lung and heart. 
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Purpose or Objective 
Automated treatment planning (AP) and multi-criteria 
optimization via Pareto navigation (MCO) are two 
important innovations within the field of radiotherapy 
S92                                                                                                                                                         ESTRO 38 
 
 
 
DVH parameters and optimization objectives were 
extracted from archived DVH reports. Data were analysed 
in SPSS. 
Results 
In 10.7% (n=19) of cases the auto-plan was directly 
accepted for treatment. In 46.9% (n=83) of cases, MUs 
were scaled before accepting the auto-plan. In 40.1% 
(n=71), the auto-plan was optimised further. In 2.3% (n=4) 
of all cases, the auto-plan was rejected entirely and a new 
plan was made manually. We could identify the following 
reasons for manual adaptations: 
  
 Bowel loop: 14.7% of plans (n=26), a bowel loop 
was near the PTV. In 4 cases MU were scaled and 
22 cases were optimised further.  
 Target coverage: Upscaling of MUs (n=43) is 
done to improve target coverage. These auto-
plans had a mean V95% of 98.87±1.12%, upscaling 
resulted in a mean V95% of 99.41±0.25% 
(p<0.001).  
 Hot or cold spots: Downscaling of MUs (n=40) is 
mainly done to reduce the high dose volume. 
Before downscaling, auto-plans had a V103% of 
1.11±1.39%, downscaling resulted in a V103% of 
0.48±0.62% (p=0.002). In 22 cases additional 
objectives were required to counteract hot or 
cold spots in the plan.  
 
Figure 1 shows PTV coverage of the auto-plan vs the 
clinical plan and denotes the reason for manual 
adaptation. These adaptations had no significant effect 
OAR mean dose (rectum, anal sphincter) (p>0.141). All 
manual plans were made due to the presence of a hip 
prosthesis or bowel loop. 
Conclusion 
Although, clinical plans were based on the auto-plan in 
97.7% of cases, the direct acceptance rate of auto-plans, 
including a post-script for fine tuning, was low at 10.2%. 
Rescaling of MU’s was the most performed adaptation, 
which is easily automated by adding an auto-prescribe 
step. Overall, the effects of plan adaptations were small 
and might not have been clinically relevant. These data 
give rise to further discussion between physicists, 
physicians and RTTs to provide inside into what manual 
adaptations would be clinically relevant. Development of 
automated decisions tools to identify non-optimal 
treatment plans may be of great value for improvement of 
auto-planning practice. 
 
OC-0182  Automated (non-coplanar) beam selection 
for IMRT in young female lymphoma patients reduces 
OAR doses 
P. Cambraia Lopes1, L. Rossi1, J. Leitão1, C. Janus1, M. 
Van de Pol1, J. Penninkhof1, B. Heijmen1 
1Erasmus MC Cancer Institute, Radiation Oncology, 
Rotterdam, The Netherlands  
 
Purpose or Objective 
There are as many variations in tumor location, shape and 
size in lymphoma patients, as in radiotherapy (RT) 
techniques clinically applied (Maraldo et al. Int J Radiat 
Oncol Biol Phys 2015, 92(1):151). This population might 
therefore benefit from patient-specific, computer 
selection of beam angles. We investigated the potential 
dosimetric advantages of automated beam angle selection 
(BAS), in both coplanar (CP) and non-coplanar (NCP) 
settings, for young mediastinal lymphoma females, with 
or without involvement of supraclavicular or axillar nodes, 
including bulky disease. 
Material and Methods 
A total of 23 patients were included with mediastinal 
lymphoma disease (PTV sizes: 97cc – 1308cc, median: 
495cc; median age: 26 years). Erasmus-iCycle was used to 
automatically generate treatment plans with/without 
BAS. The applied optimization protocol as defined by the 
‘wish-list’ containing the planning hard constraints and 
prioritized objectives was tailored to RT of young females, 
where late toxicity to breasts, heart, and lungs are of 
great concern. The prescription dose was 30 Gy. Coplanar 
(BAS-CP) and fully non-coplanar (BAS-fNCP) plans were 
generated (min. beams=5, max.=15), for couch and gantry 
angles that are possible at the treatment unit. The optimal 
number of beams and the most common couch positions 
were investigated. For a subgroup of 16 patients, CP IMRT 
plans were generated with the clinically used beam 
angles, typically 5-7 beams manually selected from (and 
close to) anterior and posterior directions (CLIN-CP). 
Results 
BAS-CP plans with the same number of beams as the CLIN-
CP plans resulted in similar OAR doses for the same PTV 
coverage (V95%=98%), but lower integral patient dose 
(V15Gy, V20Gy). The addition of CP beams (10 vs 5) 
resulted in (1) improvements in heart and lung Dmean for 
all patients, on average -0.7 Gy (max. -2.4 Gy), and -0.8 
Gy (max. -1.6 Gy) improvement respectively; (2) decrease 
in lung V5Gy by more than 5% for 6 patients; and (3) a 
decrease in patients with breast Dmean over 2 Gy (5 vs 8). 
BAS-fNCP plans showed further reductions in OAR doses 
relative to BAS-CP: (1) the average lung and heart Dmean 
were lower by 0.5 Gy and 0.7 Gy, respectively; (2) a 
decrease in heart Dmean >1 Gy was found for 8 patients 
(max. 2.4 Gy); (3) a decrease in lung Dmean ≥1 Gy for 5 
patients (max. 1.9 Gy), along with reductions in lung V5Gy 
ranging from 6–20%, and (4) less patients with breast 
Dmean over 2 Gy (3 vs 5). BAS-fNCP with 15 beams resulted 
in the largest differences with CLIN-CP, with 
improvements (mean±SD) of -1.3±1.2 Gy (max. -3.6 Gy) 
and -1.2±0.7 Gy (max. -3.0 Gy) for the heart and lung 
Dmean, respectively, and 5% lower lung V5Gy on average 
(max. 20%), while the Dmean on both breasts was <2 Gy 
for 15/16 for BAS-fNCP, compared to 13/16 with CLIN-CP. 
 
 
 
Conclusion 
We successfully implemented automated planning for 
young female lymphoma patients. Patient-specific 
computer optimization of (non-coplanar) beam angles can 
significantly reduce doses to breast, lung and heart. 
 
OC-0183  Multi-Institutional Evaluation of a Pareto 
Navigation Guided Automated Planning Solution 
P. Wheeler1, N. West2, R. Powis3, R. Maggs1, M. Chu1, 
R.A. Pearson2, N. Willis2, B. Kurec3, M. Youings3, D.G. 
Lewis1, J. Staffurth4, E. Spezi5, A.E. Millin1 
1Velindre Cancer Centre, Medical Physics, Cardiff, 
United Kingdom; 2Northern Centre for Cancer Care, 
Cancer Services and Clinical Haematology, Newcastle 
upon Tyne, United Kingdom ; 3Worcestershire Acute 
Hospitals NHS Trust, Worcestershire Oncology Centre, 
Worcester, United Kingdom ; 4Cardiff University, School 
of Medicine, Cardiff, United Kingdom ; 5Cardiff 
University, School of Engineering, Cardiff, United 
Kingdom  
 
Purpose or Objective 
Automated treatment planning (AP) and multi-criteria 
optimization via Pareto navigation (MCO) are two 
important innovations within the field of radiotherapy 
S93                                                                                                                                                         ESTRO 38 
 
 
 
treatment planning, with AP promising step changes in 
planning efficiency, and MCO enabling a more intuitive 
exploration of competing trade-offs. Recently a novel fully 
automated solution (EdgeVcc), which incorporates MCO 
within the calibration process, has been developed in 
RayStation (RaySearch Laboratories, Stockholm, Sweden) 
using scripting and validated in a single institutional 
setting. This work presents results from a further study 
across two independent centers for prostate cancer and 
aims to evaluate the use of MCO in propagating automated 
solutions across institutions with differing planning 
techniques or aims. 
Material and Methods 
For each institution (IA and IB) 30 previously treated 
prostate cancer patients were randomly allocated into a 
calibration cohort (n=10) and validation cohort (n=20). A 
set of planning goals, comprising of constraints and trade-
offs, were defined and the MCO guided calibration process 
performed on a single calibration patient. MCO enabled 
differing treatment options to be intuitively explored, 
with competing trade-offs balanced according to the 
institutional planning aims. The resultant automated 
solution was tested across all calibration patients, with 
planning goals or trade-off balancing (via MCO) refined as 
required. Following successful calibration, a single 
automated plan (VMATAuto) was generated fully 
autonomously for each patient in the validation cohort. 
VMATAuto plan quality was compared against the previously 
treated clinical plan (VMATClinical) quantitatively, using a 
range of DVH metrics, and qualitatively through blind 
review by an oncologist and dosimetrist pair based at the 
local institution. 
Results 
A summary of the quantitative and qualitative results is 
provided in Table 1, with example dose distributions 
provided in Figure 1. For both institutions automation led 
to statistically significant improvements across the 
majority of rectal dose metrics, and D98% for the low and 
intermediate (IA only) dose PTVs. VMATAuto reduced 
bladder doses for IB but for IA they were increased. There 
were also small differences in the conformality indices and 
D2% between the two techniques, with VMATClinical 
performing slightly better, however this did not prevent 
both institutions from demonstrating a clear preference 
towards VMATAuto. Across all study patients 92.5% and 95% 
of VMATAuto plans were considered equivalent or better 
than VMATClinical by the reviewing oncologist and 
dosimetrist respectively. 
 
 
 
 
Conclusion 
An MCO guided automated planning solution has been 
successfully validated against clinical practice in two 
independent institutions. The novel calibration process 
enabled intuitive adaptation of automated protocols to an 
institution’s individual planning aims and yielded plans 
more congruent with the oncologist’s clinical preference. 
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Purpose or Objective 
Automated treatment planning is an effective solution to 
generate fast, consistent treatment plans on the Pareto 
front (PF). It leads to a single treatment plan that has a 
specific trade-off between conflicting objectives. Upfront 
knowledge of the PF will allow to direct automated 
planning to a plan with a non-standard trade-off tailored 
to the individual patient and helps with configuring new 
automated planning solutions. However, even with 
automatic planning systems a quick upfront estimate of 
the PF for every patient is clinically infeasible due to the 
large number of plans that needs to be generated. Since 
the PF in principle depends only on patient anatomy and 
delivery system, the purpose of this work is to 
demonstrate the feasibility of predicting the patient 
specific PF based only on patient anatomy since only the 
anatomy varies from patient to patient. 
Material and Methods 
The inhouse TPS Erasmus-iCycle was used to generate 42 
treatment plans for 115 prostate patients delivering 60Gy 
in 20 fractions (4830 treatment plans in total). Erasmus-
iCycle uses a wish list of prioritized objectives and per 
definition generates plans on the PF. Here 42 different 
wish lists were used to create treatment plans on the PF 
spanned by rectum Dmean, the homogeneity 
(parameterized by PTV-Dmax) and the conformity, 
defined as the Dmax at 1cm distance to the PTV. All plans 
were normalized such that PTV D99% = 95%. First, for all 
patients the obtained PFs were parameterized using three 
parameters per patient that were estimated using least 
squares fitting. Then, patient specific features were 
selected to predict the parameters of the PF based on 
patient anatomy, using support vector regression with 
radial basis function kernels. The features were 
the  proportion of the rectum and average area of the 
patient outline at the slices of the PTV, the volumes of 
PTV and rectum and the radii corresponding to 1,10, 50, 
90 and 99% overlap of the PTV-rectum overlap volume 
histograms. The model was trained on 80% of the patients 
